TESS Research Foundation Selected as Part of Chan Zuckerberg Initiative Rare As One Project

MENLO PARK, Calif.--(BUSINESS WIRE)--Today, TESS Research Foundation (TESS) was announced as an awardee of the Chan Zuckerberg Initiative (CZI) Rare As One Project. TESS was selected due to its innovative, patient-led approach to finding a cure and treatments for SLC13A5 Deficiency, a rare genetic epilepsy that causes a lifetime of debilitating seizures that begin within hours of birth. TESS Research Foundation was one of only 30 patient-led organizations in the country to be selected and was a

Click to view original post